$HLTHQ
Cue Health Inc.

2021 Q4 Form 10-Q Financial Statement

#000162894521000011 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $192.5M $223.7M $4.730M
YoY Change 1351.45% 4628.94%
Cost Of Revenue $102.8M $88.57M $2.640M
YoY Change 735.06% 3254.89%
Gross Profit $89.71M $135.1M $2.090M
YoY Change 9313.43% 6364.59%
Gross Profit Margin 46.6% 60.4% 44.19%
Selling, General & Admin $44.65M $38.66M $3.713M
YoY Change 160.68% 941.1%
% of Gross Profit 49.77% 28.61% 177.66%
Research & Development $21.68M $9.079M $6.878M
YoY Change 1029.11% 32.0%
% of Gross Profit 24.17% 6.72% 329.09%
Depreciation & Amortization $6.430M $11.40M $1.000M
YoY Change 236.3% 1040.0%
% of Gross Profit 7.17% 8.44% 47.85%
Operating Expenses $66.33M $47.74M $10.59M
YoY Change 248.22% 350.71%
Operating Profit $23.38M $87.38M -$8.502M
YoY Change -229.21% -1127.7%
Interest Expense -$57.00K -$1.786M $514.0K
YoY Change -43.0% -447.47%
% of Operating Profit -0.24% -2.04%
Other Income/Expense, Net $291.0K -$80.00K $40.00K
YoY Change -121.7% -300.0%
Pretax Income $23.62M $49.45M -$8.538M
YoY Change -220.88% -679.13%
Income Tax -$10.62M $30.10M $0.00
% Of Pretax Income -44.95% 60.87%
Net Earnings $34.23M $19.35M -$8.538M
YoY Change -275.21% -326.61%
Net Earnings / Revenue 17.78% 8.65% -180.51%
Basic Earnings Per Share $140.00 -$0.52
Diluted Earnings Per Share $232.2K $0.13 -$0.52
COMMON SHARES
Basic Shares Outstanding 146.4M shares 31.55M shares 16.56M shares
Diluted Shares Outstanding 39.30M shares 16.56M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $409.9M $446.6M
YoY Change
Cash & Equivalents $409.9M $446.6M $49.17M
Short-Term Investments
Other Short-Term Assets $7.446M $2.088M
YoY Change 489.55%
Inventory $88.39M $70.74M
Prepaid Expenses $45.89M $47.92M
Receivables $104.6M $90.19M
Other Receivables $0.00 $0.00
Total Short-Term Assets $670.0M $669.5M
YoY Change 264.74%
LONG-TERM ASSETS
Property, Plant & Equipment $256.9M $247.2M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.435M $1.407M
YoY Change 2919.44%
Total Long-Term Assets $270.0M $252.5M
YoY Change 103.6%
TOTAL ASSETS
Total Short-Term Assets $670.0M $669.5M
Total Long-Term Assets $270.0M $252.5M
Total Assets $940.1M $922.0M
YoY Change 197.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.21M $35.15M
YoY Change 56.03%
Accrued Expenses $36.65M $30.17M
YoY Change
Deferred Revenue $82.17M $76.34M
YoY Change -29.01%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $166.9M $181.6M
YoY Change 7.08%
LONG-TERM LIABILITIES
Long-Term Debt $3.271M $3.841M
YoY Change
Other Long-Term Liabilities $6.356M $884.0K
YoY Change 41.24%
Total Long-Term Liabilities $6.356M $884.0K
YoY Change 41.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $166.9M $181.6M
Total Long-Term Liabilities $6.356M $884.0K
Total Liabilities $233.3M $267.6M
YoY Change -3.35%
SHAREHOLDERS EQUITY
Retained Earnings -$24.02M -$58.25M
YoY Change -78.25%
Common Stock $1.000K $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $706.8M $654.4M -$84.98M
YoY Change
Total Liabilities & Shareholders Equity $940.1M $922.0M
YoY Change 197.18%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $34.23M $19.35M -$8.538M
YoY Change -275.21% -326.61%
Depreciation, Depletion And Amortization $6.430M $11.40M $1.000M
YoY Change 236.3% 1040.0%
Cash From Operating Activities $8.849M $19.51M -$38.29M
YoY Change -94.17% -150.97%
INVESTING ACTIVITIES
Capital Expenditures -$37.56M -$19.27M -$5.684M
YoY Change -47.21% 238.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$37.56M -$19.27M -$5.684M
YoY Change -47.21% 238.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.172M 206.0M 877.0K
YoY Change 161.86% 23390.76%
NET CHANGE
Cash From Operating Activities 8.849M 19.51M -38.29M
Cash From Investing Activities -37.56M -19.27M -5.684M
Cash From Financing Activities -6.172M 206.0M 877.0K
Net Change In Cash -34.88M 206.3M -43.09M
YoY Change -144.49% -578.66%
FREE CASH FLOW
Cash From Operating Activities $8.849M $19.51M -$38.29M
Capital Expenditures -$37.56M -$19.27M -$5.684M
Free Cash Flow $46.41M $38.78M -$32.60M
YoY Change -79.19% -218.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001628945
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40590
dei Entity Registrant Name
EntityRegistrantName
Cue Health Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1562193
dei Entity Address Address Line1
EntityAddressAddressLine1
4980 Carroll Canyon Rd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
412-8151
dei Trading Symbol
TradingSymbol
HLTH
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146362598 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
446589000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121578000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
12000000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6000000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90190000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4168000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
70739000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
36842000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
47922000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13847000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2088000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1263000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
669528000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
183698000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1677000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
168642000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
103683000 USD
CY2021Q3 hlth Prepaid Rent Noncurrent
PrepaidRentNoncurrent
161000 USD
CY2020Q4 hlth Prepaid Rent Noncurrent
PrepaidRentNoncurrent
16771000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78555000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8281000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3691000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2038000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1407000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
180000 USD
CY2021Q3 us-gaap Assets
Assets
921984000 USD
CY2020Q4 us-gaap Assets
Assets
316328000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
35148000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23847000 USD
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26212000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
8822000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
37365000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
76341000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
115747000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5434000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3960000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
797000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2603000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1249000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
181629000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31225000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
67349000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50027000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10472000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
155896000 USD
CY2021Q3 hlth Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
0 USD
CY2020Q4 hlth Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
1331000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3841000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1857000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
884000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4500000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
267606000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
241405000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146362598 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27995780 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
176323000 USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
129030355 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146362598 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27995780 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
712625000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9036000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58248000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110436000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
654378000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-101400000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
921984000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
316328000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
223679000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4730000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
425601000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5572000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27031000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7531000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
64000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9079000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6878000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21150000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26558000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33084000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3694000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
56336000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7458000 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
136304000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
13232000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
258763000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
36721000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
87375000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8502000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
166838000 USD
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1786000 USD
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
514000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9752000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-274000 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-243000 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-20000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-53000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-36306000 USD
CY2020Q3 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-59560000 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-610000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1998000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-610000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-80000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
99000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49446000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8538000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
95562000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27816000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30098000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43374000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19348000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8538000 USD
us-gaap Net Income Loss
NetIncomeLoss
52188000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27816000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
140
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31554720 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16556343 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22997311 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16126647 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39304978 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16556343 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30747569 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16126647 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-61332000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
177691000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
297792000 USD
CY2021Q3 hlth Non Cash And Payment Of Stock Issuance Costs
NonCashAndPaymentOfStockIssuanceCosts
24700000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
205293000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
159000 USD
CY2021Q3 hlth Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions
46000 USD
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4586000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19967000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19348000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
654378000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-76591000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
145000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8538000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-84984000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-101400000 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
177691000 USD
us-gaap Net Income Loss
NetIncomeLoss
52188000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
417000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
297792000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
1239000 USD
hlth Non Cash And Payment Of Stock Issuance Costs
NonCashAndPaymentOfStockIssuanceCosts
24700000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
205293000 USD
hlth Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
77000 USD
hlth Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions
109000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4586000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25558000 USD
us-gaap Net Income Loss
NetIncomeLoss
52188000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
654378000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-58139000 USD
hlth Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions
729000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
242000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27816000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-84984000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27816000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26079000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4367000 USD
us-gaap Inventory Write Down
InventoryWriteDown
286000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-53000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-59560000 USD
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
25558000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
242000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1998000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-610000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3462000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
421000 USD
hlth Convertible Notes Issuance Costs
ConvertibleNotesIssuanceCosts
6000000 USD
hlth Convertible Notes Issuance Costs
ConvertibleNotesIssuanceCosts
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
883000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-75529000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
154000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
65000 USD
hlth Share Based Payment Arrangement Noncash Expense Issuance Of Fully Vested Warrant To Vendor
ShareBasedPaymentArrangementNoncashExpenseIssuanceOfFullyVestedWarrantToVendor
1239000 USD
hlth Share Based Payment Arrangement Noncash Expense Issuance Of Fully Vested Warrant To Vendor
ShareBasedPaymentArrangementNoncashExpenseIssuanceOfFullyVestedWarrantToVendor
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1857000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
16000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
86022000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
2564000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34183000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11485000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25487000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24781000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3871000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-40000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5270000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1759000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
37365000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-15052000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-119000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18298000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59245000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74637000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6123000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3524000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
885000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78161000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7008000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
100000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
235480000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5563000 USD
hlth Payments Of Redeemable Convertible Preferred Stock Issuance Costs
PaymentsOfRedeemableConvertiblePreferredStockIssuanceCosts
0 USD
hlth Payments Of Redeemable Convertible Preferred Stock Issuance Costs
PaymentsOfRedeemableConvertiblePreferredStockIssuanceCosts
3037000 USD
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
89000 USD
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
0 USD
hlth Payments Of Issuance Costs Of Convertible Notes
PaymentsOfIssuanceCostsOfConvertibleNotes
6000000 USD
hlth Payments Of Issuance Costs Of Convertible Notes
PaymentsOfIssuanceCostsOfConvertibleNotes
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
418000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
729000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
77000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
230000000 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
22062000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
82250000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1658000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4586000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
781000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
87684000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1929000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1408000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
385000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
425793000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
102599000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
329334000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36346000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129255000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14505000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
458589000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50851000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
446589000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49174000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
12000000 USD
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1677000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
458589000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50851000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5100000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
760000 USD
us-gaap Interest Paid Net
InterestPaidNet
106000 USD
hlth Early Exercised Stock Options Liability
EarlyExercisedStockOptionsLiability
109000 USD
hlth Early Exercised Stock Options Liability
EarlyExercisedStockOptionsLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
47611000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9738000 USD
hlth Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
15966000 USD
hlth Prepaid Rent Reclassified To Right Of Use Assets
PrepaidRentReclassifiedToRightOfUseAssets
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18708000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13208000 USD
hlth Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
2644000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
176322000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
297792000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
hlth Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to revenue recognition, net accounts receivable, equity-based compensation expense, product warranty reserve, the </span></div>recoverability of its long-lived assets, net deferred tax assets (and related valuation allowance) and the fair value of Company’s common warrants, Convertible Notes and common stock prior to Company’s IPO. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
12000000.0 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
300000 USD
hlth Standard Product Warranty Term
StandardProductWarrantyTerm
P12M
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
0 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
7063000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
834000 USD
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6229000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.14
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021Q2 hlth Contract With Customer Receivable Number Of Units Ordered
ContractWithCustomerReceivableNumberOfUnitsOrdered
1000000 cue_Test_Kit
CY2021Q2 hlth Notice Period For Contract Termination
NoticePeriodForContractTermination
P45D
CY2021Q2 hlth Contract With Customer Receivable Number Of Units Ordered
ContractWithCustomerReceivableNumberOfUnitsOrdered
1000 cue_Reader
CY2021Q2 hlth Purchase Agreement Number Of Units Ordered Monthly Amount
PurchaseAgreementNumberOfUnitsOrderedMonthlyAmount
300000 cue_Test_Kit
CY2021Q3 hlth Purchase Agreement Number Of Units Ordered Monthly Amount
PurchaseAgreementNumberOfUnitsOrderedMonthlyAmount
10000 cue_Test_Kit
CY2021Q2 hlth Notice Period For Contract Termination
NoticePeriodForContractTermination
P30D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
183096000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
107566000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
789000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
70739000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
36842000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
34164000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
29948000 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
10643000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4957000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21216000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1645000 USD
CY2021Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
5791000 USD
CY2020Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
1081000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1075000 USD
CY2021Q3 hlth Prepaid Expense Excluding Prepaid Inventory Current
PrepaidExpenseExcludingPrepaidInventoryCurrent
33476000 USD
CY2020Q4 hlth Prepaid Expense Excluding Prepaid Inventory Current
PrepaidExpenseExcludingPrepaidInventoryCurrent
5152000 USD
CY2021Q3 hlth Prepaid Inventory Current
PrepaidInventoryCurrent
14446000 USD
CY2020Q4 hlth Prepaid Inventory Current
PrepaidInventoryCurrent
8695000 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
47922000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13847000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
352000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
204002000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
113905000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
35360000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
10222000 USD
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
168642000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
103683000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
11400000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
1000000 USD
us-gaap Depreciation
Depreciation
24200000 USD
us-gaap Depreciation
Depreciation
4400000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
10300000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4800000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1409000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5638000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2114000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1947000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
76000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3691000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2038000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1362000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
568000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3691000 USD
CY2021Q3 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
12700000 USD
CY2021Q3 hlth Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
200000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78555000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
10316000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3960000 USD
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2603000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50027000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3841000 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2398000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
393000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
5365000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
1159000 USD
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
509000 USD
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
153000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1215000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
297000 USD
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
54000 USD
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
26000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
154000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
65000 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
2961000 USD
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
297800000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
572000 USD
us-gaap Lease Cost
LeaseCost
6734000 USD
us-gaap Lease Cost
LeaseCost
1521000 USD
CY2021Q3 hlth Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
550000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
83605947 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8344752 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.61
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1698265 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
128000 shares
CY2021Q3 hlth Employee Service Share Based Compensation Accumulated Compensation Costs Capitalized
EmployeeServiceShareBasedCompensationAccumulatedCompensationCostsCapitalized
300000 USD
hlth Employee Service Share Based Compensation Accumulated Compensation Costs Capitalized
EmployeeServiceShareBasedCompensationAccumulatedCompensationCostsCapitalized
1500000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.61
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M8D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2975821 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
310816 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
107792 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.37
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9203700 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M17D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5775902 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M14D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9260605 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y5M26D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
12900000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
12900000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19348000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.45
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-8538000 USD
us-gaap Net Income Loss
NetIncomeLoss
52188000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27816000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
14926000 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
43670000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2021Q3 hlth Number Of Letters Of Credit In Effect
NumberOfLettersOfCreditInEffect
1 letter_of_credit
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4422000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8538000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8518000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27816000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
701000 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
2142000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5123000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8538000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10660000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-27816000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31554720 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16556343 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22997311 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16126647 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
89551 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
89551 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7660707 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7660707 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39304978 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16556343 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30747569 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16126647 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
140
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12515387 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101798735 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12515387 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
101798735 shares
CY2021Q3 hlth Number Of Letters Of Credit In Effect
NumberOfLettersOfCreditInEffect
1 letter_of_credit
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
900000 USD
CY2021Q2 hlth Deferred Tax Assets Tax Credit Carryforwards Other Annual Amount
DeferredTaxAssetsTaxCreditCarryforwardsOtherAnnualAmount
4000000 USD

Files In Submission

Name View Source Status
0001628945-21-000011-index-headers.html Edgar Link pending
0001628945-21-000011-index.html Edgar Link pending
0001628945-21-000011.txt Edgar Link pending
0001628945-21-000011-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hlth-20210930.htm Edgar Link pending
hlth-20210930.xsd Edgar Link pending
hlth-20210930_cal.xml Edgar Link unprocessable
hlth-20210930_def.xml Edgar Link unprocessable
hlth-20210930_htm.xml Edgar Link completed
hlth-20210930_lab.xml Edgar Link unprocessable
hlth-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending